Gynecologic Cancer
From the Journals
In recurrent ovarian cancer, secondary surgery does not extend survival
Longer-than-expected survival times and substantial platinum sensitivity among women in the trial could have diluted an independent surgical...
Conference Coverage
Surgical staging improves cervical cancer outcomes
VANCOUVER – Surgical staging outperforms CT scans, but a key question remains.
From the Journals
Sentinel node biopsy safe for women with vulval cancer
Sentinel node biopsy in women with vulval cancer could identify those at a low risk of recurrence.
Conference Coverage
Molecule exhibits activity in heavily pretreated, HER2-positive solid tumors
NATIONAL HARBOR, MD – In a phase 1 trial of 18 evaluable patients, PRS-343, a 4-1BB/HER2 bispecific molecule,...
Opinion
Disparity in endometrial cancer outcomes: What can we do?
Black women report symptoms less, have more delays in diagnosis, and experience more frequent deviations from guideline-directed diagnostics.
Opinion
USPSTF recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer
They recommend using screening tools focusing on family history that primary care physicians can utilize to determine who should be referred for...
News
Is it time to expand the use of PARP inhibitors?
Dr. Alan P. Lyss breaks down new findings presented at the European Society of Medical Oncology Congress on the expanded use of PARP inhibitors in...
Conference Coverage
Veliparib improves PFS in high-grade serous epithelial ovarian cancer
BARCELONA – Adding veliparib to frontline CT and maintenance significantly extended PFS in women with high-grade...
Opinion
The law of unintended consequences
Dr. Alan P. Lyss examines the impact of women’s health clinic closures and excessive radiation doses in some lung cancer screening programs.
From the Journals
Pilot program benefits gynecologic cancer patients with malignant bowel obstruction
Among patients with advanced gynecologic cancer and malignant bowel obstruction, hospital length of stay decreased after the implementation of a...
Conference Coverage
PRIMA study: Niraparib maintenance improves PFS in advanced OC
BARCELONA – Niraparib improves PFS when given after first-line chemotherapy for advanced ovarian cancer, according...